Teva shares approach 20-year low amid Moody's warning and other woes | Fierce Pharma
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva Pharmaceuticals on Twitter: "Teva Global Operations NA and Complex Manufacturing Finance Leader Mayra Avila shares how she confronted a challenge head-on to find her voice. Read her story and learn more
Ran Sagiv - Senior Director, Corporate Finance at Teva Pharmaceuticals - Teva Pharmaceuticals | LinkedIn
Teva | Partnership | Direct Relief
Teva workers blockade Jerusalem industrial park as PM, CEO set to meet | The Times of Israel
Amit Hazan - Head of Corporate Finance & Banking Relations - Teva Pharmaceuticals | LinkedIn
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Michael (Mickey) Ben Moshe - VP Finance, Corporate Treasury @ Teva Pharmaceuticals - Teva Pharmaceuticals | LinkedIn
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Reports Third Quarter 2022 Financial Results
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare Finance News
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026 | Business Wire
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Here's Why Teva Pharmaceutical Industries (NYSE:TEVA) Is Weighed Down By Its Debt Load - Simply Wall St News
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
Teva Pharmaceutical Industries Ltd (TEVA) - Financial and Strategic SWOT Analysis Review
